Skip to main content
ConductScienceScienceDex

Eric Thompson

NIH Rank #16734
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 14839076Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Neurosurgery

NIH Funding · FY2025

Linked Award Amount
$989.3K
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#16,734
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Eric Thompson. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Eric Thompson as a PI. Multi-PI records show the full award amount for context.

  • 1R01CA296813-01R01
    Phase 1/2 trial of PEP-CMV + nivolumab for newly diagnosed diffuse midline glioma/high-grade glioma and recurrent diffuse midline glioma/high-grade glioma, medulloblastoma, and ependymoma (PRiME II)
    Washington University in St. Louis
    $553.2K
    award amount
  • 5R01FD007283-03R01
    Phase 2 trial of a novel peptide vaccine targeting CMV antigen for newly diagnosed pediatric high grade glioma and diffuse intrinsic pontine glioma and recurrent medulloblastoma
    Duke University
    $358.4K
    award amount
  • 5R03NS138988-02R03
    Expanding CMV peptide vaccine with novel combinations and pathologies
    Washington University in St. Louis
    $77.8K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Eric Thompson as a PI.

Washington University in St. Louis
MO
$630.9K
2 grants
Duke University
NC
$358.4K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Washington University in St. Louis
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  5. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Eric Thompson.

Daniel Bryce Landi
Duke University
2
shared awards

Explore further

Find collaborators for Eric Thompson

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →